Another study has reported that the delivery of interferon regulatory factor 2 (IRF‐2) by CRC‐derived EVs, to macrophages in SLN promotes VEGF‐C secretion, tumour‐associated lymphangiogenesis, and lymphatic metastasis. This evidence concerns the gene IRF2 and neoplasm.